The Technical Analyst
FS Development Corp. II [FSII]
Exchange: NASDAQ Sector: Financial Services Industry: Shell Companies
FS Development Corp. II Price, Forecast, Insider, Ratings, Fundamentals & Signals
-2.00% $9.80
America/New_York / 27 des 2021 @ 00:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 605.00 mill |
| EPS: | 0 |
| P/E: | 0 |
| Earnings Date: | N/A |
| SharesOutstanding: | 61.73 mill |
| Avg Daily Volume: | 0.172 mill |
| RATING 2022-02-09 |
|---|
| B+ |
| Buy |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Strong Buy | |
| Return On Equity: | Neutral | |
| Return On Asset: | Neutral | |
| DE: | Neutral | |
| P/E: | Strong Sell | |
| Price To Book: | Strong Buy |
| QUARTER GROWTHS | ||
|---|---|---|
| 2/21 | 3/21 | |
| Revenue | n/a | n/a |
| Gr.Profit | n/a | n/a |
| Ebit | n/a | |
| Asset | n/a | |
| Debt | n/a | n/a |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE 0 | sector: PE -18.15 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| N/A |
| Company: PE 0 | industry: PE -25.74 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 9.06 - 10.54 ( +/- 7.59%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2021-02-16 | Hughes Owen | Sell | 30 000 | Class B Common Stock |
| 2021-02-16 | Pakianathan Deepika | Sell | 30 000 | Class B Common Stock |
| 2021-02-16 | Mall Alisa Michelle | Buy | 0 | |
| 2012-10-11 | Marxe Austin W & Greenhouse David M | Sell | 4 316 371 | Common Stock |
| 2012-10-11 | Glarner Terrence | Sell | 5 656 | COMMON STOCK |
| INSIDER POWER |
|---|
| 0.00 |
| Last 91 transactions |
| Buy: 1 458 996 | Sell: 5 039 294 |
Forecast:
01:40 - $12.26
Live Trading Signals (every 1 min)
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $9.80 (-2.00% ) |
| Volume | 0.289 mill |
| Avg. Vol. | 0.172 mill |
| % of Avg. Vol | 168.45 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For FSII
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % |
|---|
FSII
As of December 23, 2021, FS Development Corp. II was acquired by FS Development Corp. II, in a reverse merger transaction. FS Development Corp. II does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2020 and is based in San Francisco, California.
Last 10 Buy Signals
Latest Press Releases
2021-06-29 06:00:00 - Press Release
Pardes Biosciences And Fs Development Corp. Ii Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Advancing Oral Antiviral Drugs To Treat And Prevent Sars-cov-2 Infections
Carlsbad, calif. & larkspur, calif.--(business wire)--pardes biosciences and fs development corp. ii announce merger agreement creating publicly listed company advancing oral antiviral drugs.
2021-02-16 21:36:00 - Press Release
Fs Development Corp. Ii, Sponsored By Foresite Capital, Announces Pricing Of Upsized $175 Million Initial Public Offering
San francisco--(business wire)-- #lifesciences--fs development corp. ii announced today that it priced its initial public offering of 17,500,000 shares of class a common stock at $10.00 per share.
Latest News
2021-06-29 06:00:00 - Business Wire
Pardes Biosciences and FS Development Corp. II Announce Merger Agreement Creating Publicly Listed Biopharmaceutical Company Advancing Oral Antiviral Drugs to Treat and Prevent SARS-CoV-2 Infections
CARLSBAD, Calif. & LARKSPUR, Calif.--(BUSINESS WIRE)--Pardes Biosciences and FS Development Corp. II announce merger agreement creating publicly listed company advancing oral antiviral drugs.
2021-03-04 06:20:00 - The Motley Fool
2 New Healthcare SPACs Worth Adding to Your Watch List
SPAC-mania is in full swing, and the healthcare sector is starting to pop with new offerings.
2021-02-21 16:38:05 - Seeking Alpha
U.S. IPO Weekly Recap: The IPO Market Takes Its Annual February Break In A 1 IPO Week
2021-02-16 21:36:00 - Business Wire
FS Development Corp. II, Sponsored by Foresite Capital, Announces Pricing of Upsized $175 Million Initial Public Offering
SAN FRANCISCO--(BUSINESS WIRE)-- #lifesciences--FS Development Corp. II announced today that it priced its initial public offering of 17,500,000 shares of Class A common stock at $10.00 per share.